While this is the first report of Wnt7a as a prognostic marker in breast cancer, Wnt7a has been documented to be upregulated in malignant as compared with borderline or benign ovarian tumours and to promote tumour growth in in vivo ovarian cancer models30. Here, WNT7A is linked to ovarian cancer.